Screening for sensory deficits in childhood cancer survivors
Official title: Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Run by Washington University School of Medicine · NCT05582551 · Data updated 2026-11-12
This study is trying to find a better way to check for sensory problems in childhood cancer survivors by using their treatment history to identify who needs testing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 17 Years |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | August 2, 2023 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT05582551 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are childhood cancer survivors aged 7 to 17 who completed their cancer treatment 6 months to 2 years prior and are followed at the Washington University School of Medicine.
✕Probably not a fit
Patients currently undergoing active cancer treatment or those already receiving care for sensory deficits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve the screening process for sensory deficits in childhood cancer survivors by identifying patients at risk based on their treatment history. Collaborators at Washington University School of Medicine will create a document called HPARSS that links therapy-related risks to specific screening procedures. This document will prompt primary oncology providers to implement necessary screenings and diagnostic tests for these patients. The study utilizes a cross-sectional design to address organizational barriers in timely screening.
Why it matters
Potential benefit: If successful, this study could lead to earlier detection and management of sensory deficits in childhood cancer survivors, improving their quality of life.
How similar studies have gone: Other studies have shown success in implementing screening protocols for childhood cancer survivors, indicating that this approach has potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age) * Treatment including chemotherapy and/or radiation therapy * Completion of all cancer therapy for at least 6 months and less than 2 years * Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine * Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group) * English speaking Exclusion Criteria: * Undergoing active cancer treatment * Patient under the care of the Late Effects Program at St. Louis Children's Hospital * Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening. * Parents and/or patient illiteracy * No contact with treatment team in the past two years * In foster care or without a legal guardian
Where it's running
-
St. Louis Children's Hospital - Washington University School of Medicine
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Robert J Hayashi, M.D. — Washington University School of Medicine
- Study coordinator: Robert J Hayashi, M.D.
- Email: hayashi_r@wustl.edu
- Phone: 314-454-6018
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
At-home light therapy for chemo-related nerve pain in childhood cancer survivors
This study tests whether a six-week at-home light therapy program can help childhood cancer survivors who have chemotherapy-induced peripheral neuropathy.
-
Understanding the needs of siblings of children with cancer
This study looks at the emotional struggles of siblings of kids with cancer to see how they feel and what support they need during this tough time.
-
Cognitively engaging exercise to boost thinking skills in children and teens with cancer
This trial tests whether mentally challenging physical activity can improve thinking skills and self-control (executive functions) in children and adolescents undergoing cancer treatment.
-
Examining muscle function in survivors of childhood leukemia
This study is trying to see how cancer treatment affects muscle strength and function in survivors of childhood leukemia compared to healthy kids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.